thirty-five patients with advanced breast cancer refractory to initial chemotherapy were randomized to receive two-drug doxorubicin-ccnu or three-drug doxorubicin-ccnu-vincristine ( vcr ) treatment .
C0013089
doxorubicin
C0280598
doxorubicin